The analysis revealed normal LOX-1 genes in the cell lines, supporting our hypothesis that LOX-1 overexpression in CCM is a secondary, downstream effect of the underlying pathology—as seen in other disease states—and not due to a unique LOX-1 mutation found in our cohort. Here, OLR1 is linked to cerebral cavernous malformation.